Graduate School Alumni

On May 16, 389 expected graduates – 109 medical doctors, 46 physician assistants, 80 with doctorates and 154 with master of science degrees – in the Class of 2024 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall.

Weill Cornell Medicine faculty members and alumni were honored with awards for their exemplary achievements in research, education and patient care during the institution’s commencement activities on May 15 and 16.

Students in the Weill Cornell Graduate School of Medical Sciences' Class of 2024 were honored for their academic achievements during its convocation ceremony on May 15.

The institution is constructing a modern new student residence that, when it opens in 2025, will expand the scope of the institution’s Upper East Side campus and nearly double the existing student residential living space.

More than 350 expected graduates – 104 medical doctors, 86 with doctorates and 190 with Master of Science degrees – in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.

Dr. Cheryl Dreyfus, a distinguished professor and chair of the Department of Neuroscience and Cell Biology at Rutgers-Robert Wood Johnson Medical School, has been awarded the 2023 Weill Cornell Graduate School Alumni Award of Distinction.

Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2023 for their academic achievements.

 The program's enduring goal during the past half century has been to create the next generation of leaders in biomedical research.

The award recognizes alumni for their outstanding contributions to biomedical research in education, focusing on science and scholarship, leadership, mentoring and teaching, and service to society.

Weill Cornell Graduate School of Medical Sciences honored students in the Class of 2022 for their academic achievements on May 18.

Weill Cornell Medicine honored a dozen faculty, trainees, students and staff April 25 for their outstanding service and leadership in promoting diversity at the academic medical institution.

Nursing homes acquired by private equity companies saw an increase in emergency room visits and hospitalizations among long-stay residents and an uptick in Medicare costs, according to a new study from Weill Cornell Medicine investigators. 

On Aug. 20, 106 students in Weill Cornell Medical College’s Class of 2025 received their short white coats during an outdoor, in-person White Coat Ceremony. 

Weill Cornell Medicine’s Office of Diversity and Inclusion has been recognized as a Diversity Champion by Crain’s New York Business as part of its first annual Excellence in Diversity and Inclusion Awards, announced July 15.

Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign—with more than $750 million already raised—that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.

Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.

Dr. Barbara Hempstead, dean of the Weill Cornell Graduate School of Medical Sciences, has been awarded Weill Cornell Medicine’s Joan and Sanford I. Weill Exemplary Achievement Award.

Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them.

A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision. 

A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.